SMTL ID : 5to8.1

Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.98 Å

Oligo State

monomer

Ligands

1 x 7FM: 25-(methylsulfonyl)-8-(trifluoromethyl)-5,17,18,21,22,23,24,25-octahydro-12H-7,11-(azeno)-16,13-(metheno)pyrido[3,2-i]pyrrolo[1,2-q][1,3,7,11,17]pentaazacyclohenicosin-20(6H)-one(Non-covalent)

7FM.1: 18 residues within 4Å: Chain A: L.21, G.22, E.23, G.24, V.29, E.31, A.45, V.77, M.92, E.93, L.94, Y.95, G.98, E.99, R.143, N.144, L.146, D.157 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.21, A:L.146, A:L.146 Hydrogen bonds: A:Y.95, A:Y.95

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Farand, J. et al., Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency. Bioorg. Med. Chem. Lett. (2016)

Release Date

2016-12-21

Peptides

Protein-tyrosine kinase 2-beta: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Protein-tyrosine kinase 2-beta

Related Entries With Identical Sequence